| 32514047 2020. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).
| 32479746 2020. Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.
| 32529952 2020. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.
32364527 2020. Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
32172672 2020. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
32315725 ä. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China
| 32355328 ä. Impaired interferon signature in severe COVID-19
32375560 2020. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights from the ERS-COVID-19 Study
32376308 ä. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis
| 32236983 2020. Why the immune system fails to mount an adaptive immune response to a COVID-19 infection
host complement activator MASP2 as a target of the N protein of all three viruses
| 32286536 ä. Coronaviruses hijack the complement system
32463803 2020. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.
32492165 2020. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
32514592 2020. Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression.
32456696 2020. COVID-19 patients exhibit less pronounced immune suppression compared with bacterial septic shock patients.
32502135 2020. Reduced monocytic HLA-DR expression indicates immunosuppression in critically ill COVID-19 patients.
32532524 2020. SARS-CoV-2-A Tough Opponent for the Immune System.
32416070 2020. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
32513989 2020. The inhibition of IL-2/IL-2R gives rise to CD8(+) T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia.
32409741 2020. Modulation of immune crosstalk in COVID-19.
32504059 2020. Many paths to COVID-19 lymphocyte dysfunction.
32528136 2020. Considering how biological sex impacts immune responses and COVID-19 outcomes.
32587367 2020. Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients.
32554697 2020. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.